News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Incannex Completes Loyalty Option Program to Raise A$23.6M; Current Cash at Bank is Approximately A$40.0M
Incannex Healthcare
Awakn Life Sciences Reports Fiscal Fourth Quarter and Fiscal Year January 31, 2022, Results
Awakn Life Sciences
Optimi Health Opens Canada’s Largest GMP-Grade Licensed Psilocybin Cultivation Facility
Optimi Health
Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies
Field Trip Health
Tryp Therapeutics Doses First Patient In Phase Ii Psilocybin-assisted Therapy Clinical Trial
Tryp Therapeutics
Nova Mentis Sees Rapid Enrollment in Autism Study
Nova Mentis Life Science
Blackhawk Growth Closes Investment in Blum Distributors
MindBio Therapeutics
Mydecine Innovations Group Files Prospectus Supplement
Mydecine Innovations Group
Wellbeing Digital Sciences Subsidiary IRP Health Approved as Part of Coveted Chronic Pain Centre of Excellence for Canadian Veterans Network
Wellbeing Digital Sciences
Small Pharma To Present At The KCSA Psychedelics Virtual Investor Conference On April 28, 2022
Small Pharma
Filament Health Announces Fourth Patent Issuance
Filament Health
PsyBio Therapeutics Begins Filing Global Provisional Patent Conversion Applications to Further Strengthen Biosynthetic Patent Portfolio
PsyBio Therapeutics
Psyched Wellness Announces Key Findings from the 90-Day Oral Toxicity Study on AME-1
Psyched Wellness
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.